Back to results
US 12,735,710 B2Granted
Compositions and methods for inhibiting ANGPTL3 expression
AssigneeDicerna Pharmaceuticals, Inc.
InventorsBob D. Brown, Henryk T. Dudek, Utsav Saxena, Marc Abrams, Anton Turanov
Life of this patent
Estimating the term…
Abstract
Oligonucleotides are provided herein that inhibit angiopoietin-like protein 3 (ANGPTL3) expression. Also provided are compositions including the same and uses thereof, particularly uses relating to treating diseases, disorders and/or conditions associated with ANGPTL3 expression.
Claims19
An RNAi oligonucleotide for reducing angiopoietin-like protein 3 (ANGPTL3) expression, the RNAi oligonucleotide comprising a sense strand forming a duplex region with an antisense strand, wherein:
- the sense strand comprises a nucleotide sequence as set forth in sequence:
- 5′-UCAAAAUGGAAGGUUAUACAGCAGCCGAAAGGCUGC-3′ (SEQ ID NO:
- 99);
- and
- the antisense strand comprises a nucleotide sequence as set forth in sequence:
- 5′-UGUAUAACCUUCCAUUUUGAGG-3′ (SEQ ID NO:
- 100).
4 more elements
Dependencies are inferred from the claim text.